glp 1 agonist exenatide How GLP-1 Receptor Agonists Evolved from Diabetes to Weight Loss Treatments GLP-1 Receptor Agonists and Research
Description
The injectable form is more prevalent and includes drugs such as liraglutide, exenatide, and semaglutide

Clinical trials have provided limited insight into the long-term effects, as the longest trials spanned less than six years in adults and about one year in adolescents

However, no significant improvements were observed in the MDS-UPDRS Parts II and IV

[5] When the body experiences sudden weight reduction, it can interpret this as physiological stress, prompting hair follicles to shift prematurely into the resting phase

Tirzepatide was reported in only one study, and individual drugs could not be analyzed separately

In contrast, two studies, including 41,046 exposed pregnancies and 131,407 comparator pregnancies, identified a statistically significant association with urinary congenital malformations (OR 1.24
